A clinical pharmacologist's view of drug toxicity

British Journal of Clinical Pharmacology

Volumn 42, Issue 1, 1996, Pages 53-58

  Breckenridge, Alasdair ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adverse drug reactions; Amodiaquine; Carbamazepine; Insulin resistance; Methyl dopa

Indexed keywords

AMODIAQUINE; BENOXAPROFEN; CARBAMAZEPINE; CLIOQUINOL; DIAZOXIDE; METHYLDOPA; METIPRANOLOL; NOMIFENSINE; PERHEXILINE; PRACTOLOL; REMOXIPRIDE; TEMAFLOXACIN; TERODILINE; THALIDOMIDE; THIAZIDE DIURETIC AGENT; ZIMELDINE;

ADVERSE DRUG REACTION; CONFERENCE PAPER; DETOXIFICATION; DIABETES MELLITUS; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG TOXICITY; HEMATOLOGIC DISEASE; HUMAN; INSULIN RESISTANCE; NEUROTOXICITY; OBSERVATION; PRIORITY JOURNAL;

EID: 0029684175     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.03762.x     Document Type: Conference Paper

References (19)

1. Fuller RW. The asthma death problem revisited. Br J Clin Pharmacol 1996; 42: 11-14.
2. Carstairs KC, Breckenridge A, Dollery CT, et al. Incidence of a positive direct Coombs test in patients on α-methyldopa. Lancet 1966; ii: 133-135.
3. Breckenridge A, Dollery CT, Worlledge SM, et al. Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet 1967; ii: 1265-1268.
4. Jackson GH, Proctor SJ. Disorders of blood cells. In Textbook of adverse drug reactions ed Davies DM. 4th Edition. Oxford Medical Publications 1991; 643-655.
5. Dollery CT, Pentecost BL, Samaan NA. Drug induced diabetes. Lancet 1962; ii: 735-737.
6. Samaan N, Dollery CT, Fraser R. Diabetogenic activity of benzothiadiazines. Lancet 1963; ii: 1244-1266.
7. Wilkins RW. New drugs for the treatment of hypertension. Ann Intern Med 1959; 50: 1-10.
8. Breckenridge A, Welborn TA, Dollery CT, et al. Glucose tolerance in hypertensive patients on long term diuretic therapy. Lancet 1967; i: 61-64.
9. Lewis PJ, Kohner EM, Petrie A, et al. Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment. Lancet 1976; i: 564-567.
10. Welborn TA, Breckenridge A, Rubenstein AH. et al. Serum insulin in essential hypertension and in peripheral vascular disease. Lancet 1966; i: 1336-1337.
11. Peters N, Hales CN. Plasma insulin concentrations after myocardial infarction. Lancet 1965; i: 1144-1155.
12. Morris AD, Petrie JR, Connell JM. Insulin and hypertension. J Hypertension 1994; 12: 633-642.
13. Modan M, Halkin H, Almog S, et al. Hyperinsulinaemia, a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809-817.
14. Galloway JA, Hooper SA, Spradlin CT, et al. Biosynthetic human pro-insulin. Diabetes Care 1992; 15: 666-692.
15. Grahame-Smith DG, Aronson JK. Oxford textbook of clinical pharmacology and drug therapy. Oxford University Press 1992.
16. Park BK, Pirmohamed MP, Kitteringham NR. Idiosyncratic drug reactions - a mechanistic evaluation of risk factors. Br J Clin Pharmacol 1992; 34: 377-395.
17. Hatton CSR, Peto TEA, Bunch C, et al. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet 1986; i: 411-413.
18. Clarke JB, Kitteringham NR, Park BK. Detection of anti drug IgG antibodies in patients with adverse drug reactions to amodiaquine. Int Arch Allergy Appl Immunol 1991; 95: 369-379.
19. Green VJ, Pirmohamed M, Kitteringham NJ, et al. Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. Biochem Pharmacol 1995; 50: 1353-1359.